A 68-year-old woman wasreferred for evaluation of an incidentally discovered left adrenal mass.Her chief complaint was body weight loss. She showed no symptoms or signs suggestive of Cushing's syndrome. The circadian rhythm of blood pressure was also normal. Hormonal assessment revealed an abnormal diurnal variation in serum cortisol levels, suppressed baseline plasma adrenocorticotrophic hormone, and nonsuppression of serum and urinary cortisol with the dexamethasone suppression test. Adrenal scintigraphy with 131I-6-beta-iodomethyl-norcholesterol showed uptake on the left adrenal and inhibition of the contralateral adrenal gland. She was diagnosed as pre-clinical Cushing's syndrome. Due to the lack of clinical symptoms and the risks of surgery, we emphasize the importance of careful assessment of the cortisol metabolism and scintigraphic scanning under dexamethasone suppression to avoid post-surgical Addisonian crisis. (Internal Medicine 37: 528-533, 1998) 
Introduction
Incidental adrenal tumors or "incidentaloma" are a frequently diagnosed condition both in autopsy series (1) and computed tomography (CT) carried out for unrelated reasons (2). Since the advent of sensitive noninvasive methods to image the abdomen, such as CT scanning, the discovery of incidental adrenal masses has become fairly common. Most studies report an incidence of silent adrenal tumors of 1% to 2% of patients examined by CT scanning (1, 2). In some of these patients, subtle or frank overproduction of glucocorticoids without physical signs or symptoms ofCushing' s syndrome has recently been described (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . This condition is known as "pre-clinical Cushing' s syndrome", and the prevalence ofpre-clinical Cushing's syndrome among adrenal "incidentalomas" has been found to vary between 5% and 14% (4-6). It is important to clarify whether the adrenal tumors incidentally discovered are functionally active, even when symptoms and physical signs are absent, because unilateral adrenalectomy in such a patient poses apotential risk ofAddisonian crisis (4, 5, (7) (8) (9) . We herein report a patient with pre-clinical Cushing' s syndrome who was completely asymptomatic except for a subtle glucose intolerance. Her chief complaint was body weight loss. Subsequently, she underwent adrenalectomy and required a substitutive treatment with hydrocortisone after surgery.
Case Report
A 68-year-old womanwas referred to us for the evaluation of an adrenal incidentaloma.
She originally presented to her home doctor with the complaint of body weight loss. She had no other clinical symptoms and was suspected to have a malignant tumor. In an attempt to confirm this suspicion, she underwent chest and abdominal CT, and other examinations to determine the cause of body weight loss. Her abdominal CT showed a 2 cm round, well-circumscribed mass in her left adrenal gland (Fig.1) .
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Following transfer to our hospital, we examined the possibility of adrenal cancer. The patient complained of body weight loss, yet the results of a physical examination were unremarkable; blood pressure was 120/65 mmHg, heart rate 76 bpm, height 1.55 m, and weight 44 kg. Herbody weight was 48 kg 7 months before admission. The circadian rhythm of blood pressure (ABPM-630, Colin, Tokyo) was also normal (Fig. 2) . Signs of Cushing' s syndrome, virilization and other abnormalities were not present on physical examination. Routine blood tests (serum sodium, potassium, carbon dioxide, creatinine, and fasting serum glucose) were within the normal ranges. In an oral Before surgical removal of the adrenal tumor, the patient' s serum cortisol levels were slightly elevated, accompanied by a loss of diurnal rhythm. Plasma ACTH was either low or undetectable throughout the day. Table 2 summarizes the hormonal data before and after dexamethasone administration, which disclosed slightly elevated basal urinary free cortisol and 1 7-hydroxycorticoid and no suppression of serum and urinary free cortisol after dexamethasone (Table  2 ). Serum cortisol after 2 or 8 mg dexamethasone exceeded half of the value before dexamethasone, indicating a lack of suppression of cortisol by dexamethasone. Adrenal scintigraphy with 131I-6-beta-iodomethylnorcholesterol showed uptake on the left adrenal and inhibition of the contralateral adrenal gland (Fig. 1 ). Bilateral adrenal venous catheterization was performed, demonstrating that the cortisol concentration in the adrenal venous blood from the side of the mass lesion (79.4 | ig/dl) was greater than in the contralateral side (15.6 JLig/dl).
The plasma aldosterone concentrations in the adrenal venous blood from the side of the mass lesion (150 pg/ml) was also higher than in the contralateral side (26 pg/ml). The plasma renin activities in the adrenal venous 
9 0 - Normal ranges of plasma ACTH, serum cortisol, plasma renin activity, and plasma aldosterone concentration were 9 pg/ml to 52 pg/ml, less than 25 jag/dl, 0.3 ng/ml/ h to 2.9 ng/ml/h and 30 pg/ml to 150 pg/ml, respectively.
blood from the side of the mass lesion and from the contralateral side were 0.5 ng/ml/h and 0.5 ng/ml/h, respectively. A 24-hour urine collection revealed vanillylmandelic acid of 4.99 mg/day (normal 1.50 to 4.90 mg/day), metanephrines of 0.09 mg/day (normal 0.04 to 0.18 mg/day), epinephrine of 12.3 |Ug/day (normal 3 to 41 jug/day), and norepinephrine of 121. 1 | Ug/day (normal 3 1 to 1 60 jag/day), indicating a normal adrenomedullary function. During surgery, an adrenal adenoma, weighing 5.7 g with 2.2x1.8x1.7 cm in diameter, was removed (Fig.  1) . The normal adrenal gland adjacent to the adenoma was compressed but not atrophic histologically. Post-surgical substitutive treatment with oral hydrocortisone was started and a second hormonal assessment was carried out after 2 weeks. Table 1 shows the circadian patterns of serum cortisol and plasma ACTH. Oral hydrocortisone 10 mg was administered three times a day at 8:30 AM, 12:30 PM and 18:30 PM. After surgery, plasma ACTH became higher than before surgery, but serum cortisol, plasma renin activity and plasma aldosterone were still low at 8:00 AM, the time before taking hydrocortisone.
On the day of examining the responses of serum cortisol to ACTH or corticotropin-releasing hormone, the substitutive hydrocortisone wasdiscontinued in the morning. The response of serumcortisol to the intravenous injection of either ACTH or corticotropin-releasing hormone was also suppressed (Table   3 ). After surgery, plasma glucose was 4.9 mmol//, 7. 1 mmol//, 6.7 mmol//, 7.5 mmol// and 8.2 mmol// before and 30 minutes, 60 minutes, 90 minutes and 120 minutes after 75 g oral glucose administration, respectively. The substitutive treatment with hydrocortisone was discontinued 5 months after the surgery. Her body weight was slightly decreased from 44 kg before the surgery to 41 kg at this time. One month after the discontinuation of hydrocortisone, plasma ACTH (76 pg/ml), serum cortisol (8.2 jag/dl) and plasma renin activity (0.8 ng/ml/h) were all normal; however, plasma aldosterone (10 pg/ml) was still low. The anthropometric measures of this patient showed no significant difference from a typical Japanese woman. However, her chief complaint was body weight loss. We could not find any report of patients with ovart Cushing's syndrome complicated with body weight loss. In reported cases of preclinical Cushing' s syndrome, the body weight is usually normal to slightly elevated (3-17). Thus, it is very rare to see a patient with a cortisol-producing adrenal adenoma who complains of body weight loss. Recent evidence suggests that the glucocorticoid effects to control nutrient intake and metabolism are mediated through two steroid receptor subtypes, the type I and type II receptors (18) She also showed normal blood pressure with a normal circadian rhythm of blood pressure. This normal circadian variation of blood pressure is interesting, because a loss of nocturnal fall or even a nocturnal rise in blood pressure has been reported in overt Cushing's syndrome (20). This is the first report of measuring the circadian rhythm of blood pressure in pre-clinical Cushing's syndrome, using an ambulatory blood pressure monitoring system. Adrenal scintigraphy with radioactive cholesterol has been well demonstrated to provide a reliable measure of adrenocortical function in addition to being a localizing technique (3, 10-12). Virkkala et al (10) performed thorough hormonal assessment plus scintigraphic scanning with radioactive cholesterol under dexamethasone suppression in 19 patients with incidentally-discovered adrenal tumors. They emphasized the importance of careful assessment of the cortisol metabolism and scintigraphic scanning under dexamethasone suppression in the examination of these patients. It is very important to know the degree of suppression upon the contralateral adrenal gland through analysis of a scintigraph scan, to estimate the potential risk of Addisonian crisis after adrenalectomy. In the present patient, adrenal scintigraphy with 131I-6-beta-iodomethylnorcholesterol showed uptake on the left adrenal and inhibition of the contralateral adrenal gland.
There have been several reports describing the risks of adrenocortical insufficiency after adrenalectomy in patients with pre-clinical Cushing' s syndrome (4, 5, (7) (8) (9) . In the present patient, the level of serum cortisol at 8:00 AM and the responses of serum cortisol to corticotropin-releasing hormone (CRH) and ACTH were suppressed after adrenalectomy. Although the tumor appeared to be clinically nonfunctional, these data indicate that the tumor was autonomously producing cortisol, and suppressing the contralateral adrenal gland. At the former hospital, the patient was suspected to have a malignant neoplasm, and there was the possibility that the adrenal tumor, incidentally found, might be a adrenal cancer. If unilateral adrenalectomy in this patient had been performed without sufficient hormonal study and substitutive treatment, the risk of Addisonian crisis would have been significant.
Uniform guidelines have not yet been established for the management ofpre-clinical Cushing ' s syndrome. Surgical treatment is generally recommended, to prevent the development of long-term complications of subtle corticoid excess (6). To our knowledge, the transition from pre-clinical Cushing's syndrome to overt Cushing's syndrome has been reported in only two cases (7, 13). The possibility of advancement from preclinical Cushing's syndrome to overt Cushing's syndrome seems to be low, especially in older patients. Considering the lack of clinical symptoms and the risks of surgical treatment, including postoperative adrenal insufficiency, it is imperative to carefully evaluate the necessity of surgical treatment especially in older patients. In summary, we treated a case of pre-clinical Cushing's syndrome complaining of body weight loss. The circadian rhythm of blood pressure was normal. When adrenalectomy is performed in pre-clinical Cushing's syndrome or adrenal incidentaloma, we emphasize the importance of a careful assessment of the cortisol metabolism and a scintigraphic scan under dexamethasone suppression to avoid post-surgical Addisonian crisis. It is necessary to carefully evaluate the necessity of surgical treatment especially in older patients. 
